Theratechnologies (TH) Set to Announce Quarterly Earnings on Thursday

Theratechnologies (TSE:TH) will release its earnings data before the market opens on Thursday, October 10th.

Theratechnologies (TSE:TH) last issued its quarterly earnings results on Wednesday, July 10th. The company reported C$0.03 earnings per share for the quarter. Theratechnologies had a negative return on equity of 1,116.86% and a negative net margin of 8.47%. The firm had revenue of C$30.00 million for the quarter.

Theratechnologies Stock Performance

Shares of TH opened at C$1.66 on Thursday. The company has a 50-day moving average of C$1.78 and a two-hundred day moving average of C$1.82. The stock has a market cap of C$76.33 million, a price-to-earnings ratio of -9.22, a PEG ratio of -8.50 and a beta of 1.74. The company has a debt-to-equity ratio of 562.07, a current ratio of 1.10 and a quick ratio of 0.64. Theratechnologies has a one year low of C$1.27 and a one year high of C$3.43.

About Theratechnologies

Theratechnologies Inc, a biopharmaceutical company, focuses on the development and commercialization of various therapies to address the unmet medical needs in the United States, Canada, and Europe. The company offers EGRIFTA SV for the reduction of excess abdominal fat in human immunodeficiency virus (HIV)-infected patients with lipodystrophy; and Trogarzo for the treatment of HIV-1 infection in heavily treatment-experienced adults with multidrug-resistant HIV-1 infection failing their current antiretroviral regimen.